Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE: 300026)
China flag China · Delayed Price · Currency is CNY
4.170
-0.190 (-4.36%)
Nov 14, 2024, 3:04 PM CST

Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China and internationally.

The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, healthcare services, and smart supply chain for pharmaceutical and medical devices.

It provides its products in the areas of severe disease, cardiovascular, cerebrovascular system, respiratory system, neurodegenerative, and anti-tumor.

The company was founded in 1996 and is based in Tianjin, China.

Tianjin Chase Sun Pharmaceutical Co.,Ltd
Country China
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,910
CEO Dan Zheng

Contact Details

Address:
Building B01, Entrepreneurial Headquarters Base
Tianjin, 301700
China
Phone 86 22 5962 3160
Website chasesun.cn

Stock Details

Ticker Symbol 300026
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000GF1
SIC Code 2836

Key Executives

Name Position
Dan Zheng GM and Vice Chairman
Wu Jun Lan Executive GM, Chief Financial Officer and Executive Director
Wu Sun Deputy GM, Accounting Supervisor and Director
Chun Xu Li Deputy GM, Chief Administrative Officer and Director
Rui Qiang Chen GM of Human Resource Center and Deputy GM
Kun Zhang Deputy General Manager
Xiao Zhong Lu Deputy General Manager